YOKNEAM, Israel, May 06, 2016 (GLOBE NEWSWIRE) -- Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced the launch of Lumenis Pulse™ 100H, Pulse™ 50H and Pulse™ 30H holmium laser solutions, at the 111th American Urological Association (AUA) Annual Meeting, being held in San Diego from May 6-10, 2016.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6636e2a2-b7e7-4b88-a93b-87047b2791d2
The addition of these new systems to the line of urology platforms provides healthcare facilities and surgeons a full spectrum of laser systems to select from based on their individual surgical needs and to offer their patients the best clinical care. Each of the Pulse laser systems offer exceptional performance within its category, resulting in safe, efficient and advanced patient care. The three new laser systems join the Lumenis Pulse 120H platform, the most powerful and versatile integrated laser solution in the urology space today, together creating an unparalleled and comprehensive product line.
“With the introduction of our newest holmium lasers we reinforce our commitment to innovation in the category, delivering tailored solutions that fit physician and patient needs,” said Tzipi Ozer-Armon, CEO of Lumenis. “We are proud to provide state-of-the-art offerings across market segments, delivering improved technology and ultimately enhancing the quality of care for patients.”
The Lumenis Pulse 100H, the next generation of the VersaPulse® PowerSuite™ 100 Watt system, is a versatile and enhanced laser solution for the treatment of a wide range of clinical urological indications such as, holmium laser enucleation of the prostate (HoLEP) and Stone-Dusting TM. The system includes an innovative pulse reshape function for improved hemostasis, and has a range of laser parameter combinations that can treat more than 70 indications. The system is controlled by a dual foot pedal enabling the physician high usability and autonomy in the OR.
The Lumenis Pulse 50H provides more than 130 different energy and frequency settings, it is capable of addressing any size and type of stone and soft tissue quickly and effectively. Lumenis offers a unique proposition for physicians acquiring the Pulse 50H, a modular upgradable system, providing the opportunity to widen the treatment options and further leverage their investment as they grow their practice.
Finally, the last key addition to the Pulse laser family is the Pulse 30H, which features energy per pulse of up to 5J, the highest of its kind, along with a repetition rate of 25Hz. This allows reduced procedure duration, higher stone fragmentation rate, minimal retropulsion, and maximizes the number of different types and sizes of stones, setting it apart from all competition in this power category.
The Pulse laser systems are aligned with Lumenis fibers, offering maximum fiber durability and energy utilization during procedures, setting a new standard in high- to low-power range systems.
To learn more about the Lumenis Pulse family of holmium lasers and its portfolio of innovative urology solutions, please visit the Lumenis booth #4519 at the AUA Annual Meeting.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information visit: www.lumenis.com
For further information: Glenn Silver Lazar Partners Ltd. (646) 871-8495